Issue 3, 2016

Probing for improved selectivity with dipeptide-derived inhibitors of dipeptidyl peptidases 8 and 9: the impact of P1-variation

Abstract

Selected pyrrolidines, 2-cyanopyrrolidines and heteroaromatic isoindoline analogues were evaluated as P1-residues in dipeptide-derived inhibitors of DPP8/9. Potency testing indicates that DPP8 or DPP9 specificity cannot be obtained with the selected set of P1- and P2-fragments. Nonetheless, the nanomolar DPP8/9 potencies and remarkable selectivities with respect to DPP IV and DPPII, makes inhibitors 4c and 4h suitable “leads” for future inhibitor optimization effort.

Graphical abstract: Probing for improved selectivity with dipeptide-derived inhibitors of dipeptidyl peptidases 8 and 9: the impact of P1-variation

Supplementary files

Article information

Article type
Research Article
Submitted
03 Oct 2015
Accepted
18 Nov 2015
First published
19 Nov 2015

Med. Chem. Commun., 2016,7, 433-438

Probing for improved selectivity with dipeptide-derived inhibitors of dipeptidyl peptidases 8 and 9: the impact of P1-variation

L. Heirbaut, S. van Goethem, K. Jansen, H. de Winter, N. Lamoen, J. Joossens, J. Cheng, X. Chen, A. Lambeir, I. de Meester, K. Augustyns and P. van der Veken, Med. Chem. Commun., 2016, 7, 433 DOI: 10.1039/C5MD00454C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements